Abstract
Respiratory system bears the major brunt of environmental insults. Respiratory infections such as pneumonias continue to threaten human health. The corona virus pandemic (COVID-19) is the most recent example of a respiratory infection threatening the human kind. Tuberculosis is one of the most ancient diseases which continue to pose as a clinical problem. Besides infections, there is a huge burden of chronic respiratory disorders in terms of morbidity and mortality. Chronic respiratory disease (CRD) is among the most common non-communicable diseases (NCDs) identified by the World Health Organization. Chronic obstructive pulmonary disease (COPD) is the third most common cause of death the world over. Respiratory allergies such as bronchial asthma, environmental, occupational and other interstitial lung diseases are other common chronic lung diseases which are increasing in incidence.
Several new diagnostic and treatment modalities have been added in our armamentarium to fight against these disorders. Besides the medical and surgical treatments, some of these interventions are non-pharmacological in nature such as the pulmonary rehabilitation and patient education programmes. Newer strategies and governmental programmes constitute other important steps to control the disease-burden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Barnes H, Goh NSL, Leong TL, Hoy R (2019) Silica-associated lung disease: an old-world exposure in modern industries. Respirology 24(12):1165–1175
Biddiscombe MF, Usmani OS (2018) Is there room for further innovation in inhaled therapy for airways disease? Breathe (Sheff) 14(3):216–224
Bonjour S, Adair-Rohani H, Wolf J et al (2013) Solid fuel use for household cooking: country and regional estimates for 1980–2010. Environ Health Perspect 121:784–790
Boogaard H, Walker K, Cohen AJ (2019) Air pollution: the emergence of a major global health risk factor. Int Health 11(6):417–421
Carlos WG, Dela Cruz CS, Cao B, Pasnick S, Jamil S (2020) Novel Wuhan (2019-nCoV) coronavirus. Am J Respir Crit Care Med 201:P7–P8
Cave AJE (1939) The evidence for the incidence of tuberculosis in ancient Egypt. Br J Tuberc 33:142
Cullinan P, Reid P (2013) Pneumoconiosis. Prim Care Respir J 22(2):249–252
Cypel M, Keshavjee S (2020) When to consider lung transplantation for COVID-19. Lancet Respir Med S2213-2600(20)30393-3
Dalby R, Suman J (2003) Inhalation therapy: technological milestones in asthma treatment. Adv Drug Deliv Rev 55:779–791
Dhooria S, Agarwal R, Dhar R, Jindal A, Madan K, Aggarwal AN et al (2018) Consensus statement for the diagnosis and treatment of idiopathic pulmonary fibrosis in resource constrained settings. Indian J Chest Dis Allied Sci 60:93–121
Fajt ML, Wenzel SE (2015) Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol 135(2):299–310
Fishman AP (1998) Milestones in the history of pulmonary medicine. In: Fishman’s pulmonary diseases and disorders, 3rd edn. McGraw-Hill, New York
GBDS (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1211–1259
Global Initiative for Chronic Obstructive Lung Disease (2020) Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease (2020 report). https://goldcopd.org. Accessed 20 Sept 2020
Gordon SB, Bruce NG, Grigg J et al (2014) Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med 2:823–860
Hoek G, Krishnan RM, Beelen R, Peters A, Ostro B, Brunekreef B et al (2013) Long-term air pollution exposure and cardio-respiratory mortality: a review. Environ Health 12(1):43
India State-Level Disease Burden Initiative CRD Collaborators (2018) The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health 6:e1363–e1374
Jaggi OP (1961) Chest diseases in ancient Hindu medicine. Indian J Chest Dis 3:124–128
Ji W, Lim MN, Bak SH et al (2018) Differences in chronic obstructive pulmonary disease phenotypes between non-smokers and smokers. Clin Respir J 12(2):666–673
Jindal SK (2012a) COPD: the unrecognized epidemic in India. J Assoc Physicians India 60(Suppl):14–16
Jindal SK (2012b) Research in clinical sciences. Indian J Chest Dis Allied Sci 54:175–182
Jindal SK (2013) Silicosis in India: past and present. Curr Opin Pulm Med 19:163–168
Jindal SK (2018) Chronic obstructive pulmonary disease in non-smokers—is it a different phenotype? Indian J Med Res 147(4):337–339
Jindal SK, Aggarwal AN, Gupta D, Agarwal R, Kumar R, Kaur T, Chaudhry K, Shah B (2012) Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis 16(9):1270–1277
Jindal SK, Aggarwal AN, Christopher DJ, Dhar R, Jindal A (2020a) Cloth face covers—a sustainable measure to mitigate COVID-19. Int J Tuberc Lung Dis. https://doi.org/10.5588/ijtld.20.0220
Jindal SK, Aggarwal AN, Jindal A et al (2020b) Exacerbation rates are higher in chronic obstructive pulmonary disease in non-smokers in India. Int J Tuberc Lung Dis 24(12):1272–1278
Jindal SK, Aggarwal AN, Jindal A (2020c) Household air pollution in India and respiratory diseases: current status and future directions. Curr Opin Pulm Med 26(2):128–134
Katz AM (1959) Hippocrates and the plane tree on the island of Cos. Arch Intern Med 104:653–657
Keers RY (1978) Pulmonary tuberculosis. A journey down the centuries. Bailliere-Tindall, London
Khilnani GC, Tiwari P (2018) Air pollution in India and related adverse respiratory health effects: past, present, and future directions. Curr Opin Pulm Med 24(2):108–116
Kistler KD, Nalysnyk L, Rotella P, Esser D (2014) Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature. BMC Pulm Med 14:139
Lazarus AA, Philip A (2011) Asbestosis. Dis Mon 57(1):14–26
Leidner AJ, Murthy N, Chesson HW, Biggerstaff M, Stoecker C, Harris AM, Acosta A, Dooling K, Bridges CB (2019) Cost-effectiveness of adult vaccinations: a systematic review. Vaccine 37(2):226–234
Mayer K, Hamilton C (2010) Synergistic pandemics: confronting the global HIV and tuberculosis epidemics. Clin Infect Dis 50 Suppl 3:S67–S70. https://doi.org/10.1086/651475
Mishra PK, Samarth RM, Pathak N, Jain SK, Banerjee S, Maudar KK (2009) Bhopal Gas Tragedy: review of clinical and experimental findings after 25 years. Int J Occup Med Environ Health 22(3):193–202
Mortimer K, Gordon SB, Jindal SK, Accinelli RA, Balmes J, Martin WJ II (2012) Household air pollution is a major avoidable risk-factor for cardiopulmonary disease. Chest 142:1308–1315
Nasim F, Sabath BF, Eapen GA (2019) Lung cancer. Med Clin North Am 103(3):463–473
National Strategic Plan for Tuberculosis Elimination (2017–2025) Central TB Division, Ministry of Health and Family Welfare, Government of India. www.tbcindia.nic.in. Accessed 15 Sept 2020
Nunn JF (1996) Ancient Egyptian medicine. University of Oklahoma Press, Norman
Ogura T, Taniguchi H, Azuma A, Inoue Y, Kondoh Y, Hasegawa Y et al (2015) Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 45:1382–1392
Papi A, Saetta M, Fabbri L (2017) Severe asthma: phenotyping to endotyping or vice versa? Eur Respir J 49:1700053
Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agrò FE (2020) COVID-19 diagnosis and management: a comprehensive review. J Intern Med 288(2):192–206
PMUY (Pradhan Mantri UjjwallaYojna) (2016) Ministry of Petroleum & Natural Gas, Govt of India. https://pmuy.gov.in/about.html. Accessed 18 Sept 2020
Rivera GA, Wakelee H (2016) Lung cancer in never smokers. Adv Exp Med Biol 893:43–57
Selwyn-Brown A (1938) The physician throughout the ages, vol I. Capehart-Brown Co., Inc. Publishers, Times Building, New York
Shira Doron S, Davidson LE (2011) Antimicrobial stewardship. Mayo Clin Proc 86(11):1113–1123
Singh S, Collins BF, Sharma BB, Joshi JM, Talwar D, Katiyar S et al (2017) Interstitial lung disease in India. Results of a prospective registry. Am J Respir Crit Care Med 195(6):801–813
Steingart KR, Sohn H, Schiller I, Kloda LA, Dendukuri N (2013) Xpert® MTB/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1:CD009593
Supreme Court of India (2009) Writ petition (Civil) No. 110 of 2006. No. 318926, dated 3.5.2009
ten Klooster L, Nossent GD, Kwakkel-van Erp JM, van Kessel DA, Oudijk EJ, van de Graaf EA et al (2015) Ten-year survival in patients with idiopathic pulmonary fibrosis after lung transplantation. Lung 193:919–926
Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG et al (2013) An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733–748
Udwadia FE (2000) Man and medicine—a history. Oxford University Press, New Delhi
Vancheri C, Kreuter M, Richeldi L, Ryerson CJ, Valeyre D, Grutters JC et al (2018) Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis: results of the INJOURNEY trial. Am J Respir Crit Care Med 197:356–363
WHO (2018) Third United Nations High-level Meeting on NCDs. Non-communicable diseases and their risk factors. https://www.who.int/ncds/governance/third-un-meeting. Accessed 20 Sept 2020
World Health Organization (2020) Antimicrobial resistance. Key facts. https://www.who.int. Accessed 22 Sept 2020
Young KA, Dilling DF (2019) The future of lung transplantation. Chest 155(3):465–473
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Jindal, S.K., Jindal, A. (2022). Respiratory Disorders: Contemporary Issues in 2020. In: Sobti, R., Ganju, A.K. (eds) Biomedical Translational Research. Springer, Singapore. https://doi.org/10.1007/978-981-16-8845-4_8
Download citation
DOI: https://doi.org/10.1007/978-981-16-8845-4_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-8844-7
Online ISBN: 978-981-16-8845-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)